Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-710-0 | CAS number: 109-83-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- other: a case report
- Adequacy of study:
- other information
- Study period:
- not reported, published 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented case report.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 993
Materials and methods
- Study type:
- poisoning incident
- Endpoint addressed:
- not applicable
Test guideline
- Qualifier:
- no guideline required
- GLP compliance:
- no
Test material
- Reference substance name:
- 2-methylaminoethanol
- EC Number:
- 203-710-0
- EC Name:
- 2-methylaminoethanol
- Cas Number:
- 109-83-1
- Molecular formula:
- C3H9NO
- IUPAC Name:
- 2-(methylamino)ethan-1-ol
- Details on test material:
- For the development of films a liquid activator containing 2-methylamino ethanol was used. A product which contained boric acid and ethanol was used as stabilizer.
Constituent 1
Method
- Subjects:
- - Number of subjects exposed: 1
- Sex: woman
- Age: 55 years
- Race: european
- Demographic information: From 1954 through 1979 the patient held different jobs which did not involve exposure to specific chemicals. From 1979 through 1989 she was employed as a secretary at a public driver' licence office, and her prime task was to take and develop photographs.
- Known diseases: appendectomy, extrauterine pregnancy, two uterine abrasions after menorrhagia, histerectomy because of myoma uteri, myalgia nuchae and periodically slightly elevated blood pressure.
- Other: The patient is non-smoking and has never used alcoholic beverages. - Ethical approval:
- not specified
- Route of exposure:
- other: inhalation and dermal
- Reason of exposure:
- unintentional, occupational
- Exposure assessment:
- estimated
- Details on exposure:
- The bottle containing liquid activator was generally left open during the entire working day. The film negatives which were still covered by a thin layer of the liquid were kept in an open bucket permitting continuous evaporation of the liquid. To enhance the fixation process of the photographs the patient used to hold the negative in one hand, while holding a hair-dryer in the other, blowing each negative film dry for about three minutes. on average she treated about 40 photographs a day in this way, peaking up to 100. She also cleaned the photographic machine with water every day. Sometimes the 2-methylaminoethanol liquid leaked from the photographic machine and she wiped it up from the floor using paper tissues without protecting her hands with gloves. The photographic laboratory was about 2x3 m² and had no artificial ventilation.
- Examinations:
- - Urine analysis: yes
- Haematology: yes
- Lung function parameters: no
- Other: S gamma-glutamyl transpeptidase and S-Alkaline phosphatase and trombocyte tests, ERCP examination, immunological tests, neurological and EEG examinations, liver biopsy, cysto-retroscopy and urography, cholecystectomy - Medical treatment:
- no data
Results and discussion
- Clinical signs:
- From about 1983 the patient developed irritative symptoms in the mucosa of the eyes, nose, and mouth. From about 1987 she bagan experiencing nausea when eating fat-containing food. She fainted a couple of times and had periodically a sensation of diffuse vertigo. She also developed macroscopic haematuria during the fall of 1987, lasting for several months. From 1989 and onwards she had several episodes with spontaneous haematomas occuring on arms and leggs and several warts developed on the patient' hands and feet, in particular under her right plantar pedis. She had never had warts before. On one ocassion in July 1989 she lost consciousness when driving her car, resulting in a minor accident, but she was not injured.
- Results of examinations:
- - Urine analysis: macroscopic haematuria during the fall of 1987 and of 1989. Both falls were without pathological findings either by urography or by cystourethroscopy
- Haematology: The results from blood failed to explain the haematuria. Regarding spontaneous haematomas: The thrombocyte-count presented low figures at two examinations: 136 x 10ˆ9/L in 1989, and 142 x 10ˆ9/L in 1990 with the reference level 150-450 x 10ˆ9/L: Other haematological paramaters have been normal at a number of controls.
- Other:
- Liver function: The histological findings of a liver biopsy sampled in May 1989 indicated a slight but unspecific parenchymal affection;
- Cysto-and urography revealed no abnormalities;
- More or less by chance a concrement was found in the gallbladder;
- S-gamma-glutamyl transpeptidase and S-Alkaline phosphatase were both significantly elevated (before and after cholecystectomy). Both these parameters remained elevated despite the operation, yet, as revealed in the following data, the elevated figures do not present a consistent pattern (Table 1).
- The ERCP-examination presented no abnormalities;
- Immunological tests performed to evaluate the possibility of chronic active hepatitis and primary biliary cirrhosis were negative;
- Regarding the accident when driving car: neurological and EEG examinations indicated an obvious focal epileptic activity localized to the fronto-temporal region. - Effectivity of medical treatment:
- not applicable
- Outcome of incidence:
- Cholecystectomy was carried out in January 1988.
Any other information on results incl. tables
Table 1: Enzyme levels
|
S-gamma-glutamyl transpeptidase (U/L) |
S-Alkaline phosphatase (U/L) |
June 1988 |
345 |
344 |
January1989 |
537 |
377 |
June 1989 |
311 |
349 |
May 1990 |
186 |
269 |
August 1990 |
311 |
- |
July 1991 |
295 |
352 |
The S-GGT reference level = 5 -50;
The S-AP reference level = 0 -275.
Applicant's summary and conclusion
- Conclusions:
- There is no evidence that exposure to 2-methylaminoethanol may result in a pattern of symptomps and signs which involves different organs as well as stimulation of the central nervous system. There is possible relationship between the reported exposure by inhalation and by skin and the irritation of the mucous membranes.
- Executive summary:
This report presents a patient who during exposure to 2 -methylaminoethanol developed prolonged haematuria, pathologic liver functions tests, and multiple skin warts. No information could be found in the literature, explaining this unusual combination of illness and symptoms.
Human injuries have been reported after inhalation. In animal testing, repeated exposures might cause liver degeneration and nephritis. 2 -methylaminoethanol could also act as a precursor for choline. In animals, alteration of lipid metabolism and development of fatty liver has been observed after a choline deficiency. There was no information found on whether exposure to 2 methylaminoethanol interferes with regular choline functions. There is some evidence that mammalian tissues can produce PMMEA (phosphatidylmonomethylethanolamine) and PDMAE (phosphatidyl-dimethylethanolamine) directly from their corresponding aminoalcohols by a base exchange type reaction. It has been indicated that either these phospholipids or the enzymes may be responsible for their formation and could thus be involved in the process of message transmission across biological membranes (references cited in the original paper). However, there is no apparent explanation for the manifestation of multi-organ disease and its possible relation to the exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.